HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: HIV Risk Reduction in Youth in the Bahamas [NA]
Wayne State University completed a clinical trial evaluating HIV risk-reduction strategies among youth in the Bahamas.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy [Phase 4]
Phase 4 trial update on simplifying HIV treatment by using elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine with darunavi…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients [Phase 2]
This document reports the completion of a Phase 2 pilot study evaluating dolutegravir monotherapy in HIV-1 virologically suppressed patients…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
This update summarizes the results of a completed trial investigating breast milk composition and early infant growth and infectious disease…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Strength Training With Vascular Occlusion in Patients Harboring With HIV/Aids [NA]
A University of Sao Paulo-sponsored trial evaluating strength training with vascular occlusion in patients with HIV/AIDS focusing on cardiov…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults [Phase 2]
An update on a Phase 2 trial evaluating UB-421 as monotherapy in HIV-infected adults; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption [Phase 1]
A Phase 1 trial of the HIV-neutralizing antibody VRC01 (VRC-HIVMAB060-00-AB) in people with chronic HIV infection undergoing analytical trea…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in Care [NA]
This clinical trial update reports a study from UC Berkeley exploring whether social norms and priming can improve adherence to antiretrovir…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk [NA]
A completed clinical trial tested a tailored socio-contextual intervention to reduce HIV risk among individuals with repeat sexually transmi…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) [Phase 4]
This Phase 4 pharmacokinetic study evaluated optimal dosing of first-line tuberculosis and antiretroviral drugs in children and has complete…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Pilot Study of Diflunisal in HIV-infected Adults [Phase 4]
This update reports the termination of a Phase 4 pilot study evaluating diflunisal in adults with HIV infection.
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Enhancing PrEP in Community Settings (EPIC) [NA]
The EPIC trial evaluating strategies to enhance PrEP use in community settings has completed.
-
CLINICAL_TRIALS research · 2017-10-26Clinical Trial Update: Men's Club: Impact of Male Partner Involvement on Initiation and Sustainment of Exclusive Breastfeeding Among Postpartum Women [NA]
This clinical trial examines whether involvement of male partners influences initiation and sustainment of exclusive breastfeeding among pos…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru [Phase 3]
Phase 3 trial in Lima, Peru evaluated community-based accompaniment with supervised antiretrovirals for people with HIV infection and Acquir…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men [NA]
A Chinese study is evaluating an HIV risk assessment tool to promote HIV testing among men who have sex with men. The current status of the …
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2) [Phase 3]
Phase 3 trial results for switching virologically suppressed HIV-1 adults to a dolutegravir + rilpivirine regimen from their current ART; re…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Comprehensive Triaged HIV Prevention in Tanzania [Phase 2]
A Phase 2 HIV prevention trial conducted in Tanzania has completed, as reported by the sponsor Medical University of South Carolina.
-
CLINICAL_TRIALS research · 2017-10-23Clinical Trial Update: A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers [Phase 1]
This is a Phase 1 clinical trial evaluating the combination of rifampicin and dolutegravir in healthy volunteers. It is sponsored by St. Ste…
-
FDA approval · 2017-10-20FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients [Phase 2]
A Phase 2 trial evaluated the effect of aspirin on abacavir-induced platelet reactivity in HIV-infected patients. The study status is comple…
-
FDA approval · 2017-10-20FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for REYATAZ (atazanavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS research · 2017-10-20Clinical Trial Update: Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen [Phase 3]
A Phase 3 trial evaluating bone mineral density in HIV-1–infected adults who switch from tenofovir to a dolutegravir plus rilpivirine regime…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults [Phase 3]
A Phase 3 study evaluating switching virologically suppressed HIV-1 adults from EFV/FTC/TDF to FTC/RPV/TAF; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Emtricitabine/Tenofovir Alafenamide as Salvage ART [Phase 2]
A Phase 2 trial of emtricitabine/tenofovir alafenamide as salvage ART in HIV was terminated, with results posted in October 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome [NA]
An update on trial results evaluating a point-of-delivery prenatal test delivered via mobile health to improve birth outcomes.